-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $9

Benzinga·07/09/2025 15:43:04
Listen to the news
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $18 to $9.